By Dani Kass ( August 27, 2018, 8:57 PM EDT) -- Ampio Pharmaceuticals Inc. misled investors into believing that its arthritis treatment was going to be approved by the U.S. Food and Drug Administration, causing shares to drop when the company disclosed that the clinical trial had not been sufficient, according to a proposed class action in California federal court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.